Literature DB >> 10544106

Genetic analysis reveals that both haemagglutinin and neuraminidase determine the sensitivity of naturally occurring avian influenza viruses to zanamivir in vitro.

S J Baigent1, R C Bethell, J W McCauley.   

Abstract

The basis of differential sensitivity of replication of influenza viruses to the neuraminidase-specific inhibitor zanamivir was examined using four avian influenza viruses and reassortants produced between them. IC(50) values for inhibition of neuraminidase activity by zanamivir were similar for each of the four viruses, whereas the haemagglutinating activity of each of the viruses was relatively insensitive to zanamivir. However, the four viruses showed distinct zanamivir-sensitivity profiles in tissue culture. Analysis of the reassortant viruses showed that sensitivity was determined by the haemagglutinin gene (segment 4) and the neuraminidase gene (segment 6) and was independent of the remaining six RNA segments. Decreased sensitivity to zanamivir was associated with possession of a haemagglutinin that is released from cells with decreased dependence on neuraminidase and with possession of a neuraminidase that has a short stalk region. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544106     DOI: 10.1006/viro.1999.9931

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors.

Authors:  Vasiliy P Mishin; Dmitri Novikov; Frederick G Hayden; Larisa V Gubareva
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

2.  A 27-amino-acid deletion in the neuraminidase stalk supports replication of an avian H2N2 influenza A virus in the respiratory tract of chickens.

Authors:  Erin M Sorrell; Haichen Song; Lindomar Pena; Daniel R Perez
Journal:  J Virol       Date:  2010-09-08       Impact factor: 5.103

3.  Identification of the neoplastically transformed cells in Marek's disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37.

Authors:  Shane C Burgess; T Fred Davison
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

4.  Emergence and genetic variation of neuraminidase stalk deletions in avian influenza viruses.

Authors:  Jinling Li; Heinrich Zu Dohna; Carol J Cardona; Joy Miller; Tim E Carpenter
Journal:  PLoS One       Date:  2011-02-23       Impact factor: 3.240

5.  Detection of resistance mutations to antivirals oseltamivir and zanamivir in avian influenza A viruses isolated from wild birds.

Authors:  Goran Orozovic; Kanita Orozovic; Johan Lennerstrand; Björn Olsen
Journal:  PLoS One       Date:  2011-01-06       Impact factor: 3.240

6.  Biophysical measurement of the balance of influenza a hemagglutinin and neuraminidase activities.

Authors:  Donald J Benton; Stephen R Martin; Stephen A Wharton; John W McCauley
Journal:  J Biol Chem       Date:  2015-01-13       Impact factor: 5.157

Review 7.  Carbohydrate-based drugs launched during 2000-2021.

Authors:  Xin Cao; Xiaojing Du; Heng Jiao; Quanlin An; Ruoxue Chen; Pengfei Fang; Jing Wang; Biao Yu
Journal:  Acta Pharm Sin B       Date:  2022-05-23       Impact factor: 14.903

8.  Evolutionary interactions between haemagglutinin and neuraminidase in avian influenza.

Authors:  Melissa J Ward; Samantha J Lycett; Dorita Avila; Jonathan P Bollback; Andrew J Leigh Brown
Journal:  BMC Evol Biol       Date:  2013-10-09       Impact factor: 3.260

9.  Strain-specific antiviral activity of iminosugars against human influenza A viruses.

Authors:  S Hussain; J L Miller; D J Harvey; Y Gu; P B Rosenthal; N Zitzmann; J W McCauley
Journal:  J Antimicrob Chemother       Date:  2014-09-15       Impact factor: 5.790

10.  Sequence Matching between Hemagglutinin and Neuraminidase through Sequence Analysis Using Machine Learning.

Authors:  He Wang; Yongjian Zang; Yizhen Zhao; Dongxiao Hao; Ying Kang; Jianwen Zhang; Zichen Zhang; Lei Zhang; Zhiwei Yang; Shengli Zhang
Journal:  Viruses       Date:  2022-02-25       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.